Indication
Generalized anxiety disorder
Generalized anxiety disorder is a chronic psychiatric disorder of the central nervous system characterized by persistent, excessive, and difficult-to-control worry and apprehension regarding everyday activities and events. Read more about Generalized anxiety disorder
266 drugs 124 manufacturers
Drugs that treat it
Common Generalized anxiety disorder therapies.
ESCITALOPRAM OXALATE
VENLAFAXINE HCL ER (venlafaxine HCl)
BUSPIRONE HCL
DULOXETINE HCL
ALPRAZOLAM
BUSPIRONE HCL
PAROXETINE HCL
ALPRAZOLAM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonGeneralized anxiety disorder is a chronic psychiatric disorder of the central nervous system characterized by persistent, excessive, and difficult-to-control worry and apprehension regarding everyday activities and events.
Pathophysiologically, it involves altered functional connectivity and heightened activity within the amygdala, prefrontal cortex, and frontolimbic circuits, along with dysregulation of neurotransmitter systems including gamma-aminobutyric acid, serotonin, and norepinephrine.
Clinically, this pervasive worry persists for at least six months and is accompanied by somatic and autonomic symptoms such as muscle tension, motor restlessness, easy fatigability, difficulty concentrating, irritability, and sleep disturbances, leading to significant functional impairment.
- nih.gov
Generalized anxiety disorder is a chronic psychiatric disorder of the central nervous system characterized by persistent, excessive, and difficult-to-control worry and apprehension regarding everyday activities and events
- nih.gov
Generalized anxiety disorder is a chronic psychiatric disorder of the central nervous system characterized by persistent, excessive, and difficult-to-control worry and apprehension regarding everyday activities and events
- nih.gov
Generalized anxiety disorder is a chronic psychiatric disorder of the central nervous system characterized by persistent, excessive, and difficult-to-control worry and apprehension regarding everyday activities and events Pathophysiologically, it involves altered functional connectivity and heightened activity within the amygdala, prefrontal cortex, and frontolimbic circuits, along with dysregulation of neurotransmitter systems including gamma-aminobutyric acid, serotonin, and norepinephrine
- mdpi.com
Pathophysiologically, it involves altered functional connectivity and heightened activity within the amygdala, prefrontal cortex, and frontolimbic circuits, along with dysregulation of neurotransmitter systems including gamma-aminobutyric acid, serotonin, and norepinephrine
- nih.gov
Clinically, this pervasive worry persists for at least six months and is accompanied by somatic and autonomic symptoms such as muscle tension, motor restlessness, easy fatigability, difficulty concentrating, irritability, and sleep disturbances, leading to significant functional impairment
- nih.gov
Clinically, this pervasive worry persists for at least six months and is accompanied by somatic and autonomic symptoms such as muscle tension, motor restlessness, easy fatigability, difficulty concentrating, irritability, and sleep disturbances, leading to significant functional impairment
Personalize your experience
Follow Generalized anxiety disorder and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.